Current status

Current status

In October 2024, the below number of individuals had been recruited in Swedegene:


Angioedema

540

Anaphylaxis

148

Urticaria

201

Other allergic reactions

127

Cough related to ACE-inhibitors

148

Osteonecrosis and atypical fractures due to bisphosphonates

144

Phototoxic reactions (mainly due to topical NSAIDs)

51

Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs 

302

Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)

72

Hyponatremia/SIADH due to antidepressants and antiepileptics

41

CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics

95

Stevens-Johnson syndrome/Toxic epidermal necrolysis

67

Tendon-rupture from flouroquinolones

33

Liver toxicity

469

Rhabdomyolysis related to statins/fibrates

52

Torsade de Pointes/QT-prolongation

24

Narcolepsy associated with Pandemrix

85

Hypersomnia associated with Pandemrix

14

Pancreatitis

101

Alopecia

27

Bleedings from new oral anticoagulants (NOACs)

160

Lack of efficacy of NOACs

33

Pneumonitis

44

Renal toxicity

103

Ankle oedema from calcium channel blockers

46

Gingival hyperplasia from calcium channel blockers

17

Adverse reactions to Covid-19 vaccines

881

Thyroiditis

18

Gastrointestinal reactions to medication for Parkinson’s disease

2

Controls

568

Total number of cases

4613

unsplash